The eyeforpharma organization recently became part of
Thomson Reuters, under its new Reuters Events division.
The eyeforpharma mission is to make the industry more
open and valued, sharing intelligence and best practices
to help achieve more transparency and trust. It provides
a hub for senior-level pharma executives, patient groups
and other health stakeholders to exchange ideas and
observe shifting trends and practices.
At the eyeforpharma awards they recognized meaningful
innovation that has an impact on our effectiveness and
Chairman Paul Simms said “With 500 nominations, our
judges – a mixture of patients and health professionals – deliberated hard for many hours, finally settling on
just 16 winners, each exemplifying the very best work
in pharma. By ‘best,’ we mean not just internal successes
(like revenue or ROI), but real impact on patients, caretakers and international health systems. This is the night
I feel most proud to work in this industry – the range and
quality of solutions shows we can make a real difference.”
Innovators Across the Industry
Teva, Sanofi, Biomarin, Janssen and Others Recognized
at eyeforpharma Awards
On December 11th in Philadelphia, the eyeforpharma Awards 2019 celebrated
16 winners making genuine innovation visible, setting the bar higher and
broadening the possibilities for pharma by showing what can be achieved.
MOST VALUABLE HEALTHCARE/HCP INITIATIVE
A Global Rare Disease Education Campaign
Reaching target physicians globally with a high-quality,
in-depth educational message about a rare disease was the
challenge BioMarin faced when it set out to educate HCPs
around the world about MPS (mucopolysaccharide) disorders. It used Figure 1, a mobile app that helps healthcare
professionals share cases to improve patient outcomes. Together with Dr. Chris Hendriksz, a pediatrician and expert
in MPS, they collaborated to identify a broader educational
initiative to address an unmet need. For Figure 1, this campaign represented a chance to prove the value of both the
app and its educational platform on a global scale.